New research confirms that regardless of age or severity of COVID-19 infection, prolonged effects on cognitive function are possible.
COVID-19’s impact on brain function is just beginning to be understood. It’s been known that COVID-19 patients treated in the hospital, particularly those who have respiratory support, experience delirium and other cognitive effects after leaving the hospital. Additionally, physicians and patients have reported symptoms of “long-COVID,” in which the physical effects of the infection continued long after the infection has cleared.
Long COVID is recognized by the CDC and can include any of symptoms, including cough, chest pain, fatigue, change in taste or smell and even brain fog. Long-COVID may be considered a disability by the U.S. Health and Human Services under the Americans with Disability Act.
A new study, published in October 2021 in JAMA Network Open, seems to confirm that even months after contracting COVID-19, some patients experience problems with memory, processing speed, executive function, and other cognitive impairments.
The biggest takeaway from the study is that COVID-19 of any severity and for adults in any age group can have prolonged effects on cognitive functioning, even months after viral recovery, lead investigator Jacqueline H. Becker, Ph.D., division of general internal medicine at Icahn School of Medicine at Mount Sinai, New York, said by email.
“It is well known that individuals can sustain cognitive deficits after critical illness, particularly older adults and those with other comorbid diseases. Our findings add to this knowledge by demonstrating a high frequency of cognitive impairment in a relatively young cohort across the spectrum of disease severity, even after controlling for potentially confounding factors such as depression and other comorbidities,” she said.
One limitation suggested by investigators is the potential for sampling bias. In this study, investigators followed up with 740 patients seen at the Mount Sinai Health System for an COVID-19 infection either in the outpatient setting, the emergency department, or an in-hospital setting.
Patients were given several cognitive assessment tests. Investigators found that there was a high frequency of cognitive impairment several months after patients contracted COVID-19. Hospitalized patients were more likely to have impairments in attention, executive function, category fluency, memory encoding than those seen on an outpatient setting. Patients treated in the emergency department were more likely to have impaired category fluency and memory encoding than those treated in the outpatient setting.
Investigators said the results are consistent with other studies of cognitive impairment resulting from COVID-19 infections, but patients in this study tended to be younger with a mean age of 49 and range of 38 to 59 years of age.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More